Dark

MMSI
Merit Medical Systems Inc
stock NASDAQ

At Close

Aug 14, 2026 3:59:57 PM EDT

90.78USD+0.304%(+0.28)729,848

75.68Bid 111.53Ask 35.85Spread

Pre-market

Aug 13, 2026 9:28:00 AM EDT

92.00USD+1.657%(+1.50)0

After-hours

Aug 12, 2026 4:11:30 PM EDT

91.20USD+0.044%(+0.04)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 17, 2022

04:55PM EST Merit Medical Systems to AnnounceFourth Quarter and GlobeNewswire Inc

Nov 23, 2021

09:28AM EST UPDATE: Merit Medical Says Proposed Settlement Calls For Payment Of $18.25M In Resolution Of All Claims Asserted Against Co., Other Defendants, ~$8.5M Of Settlement Payment Expected To Be Satisfied With Proceeds Of Available Insurance Benzinga

09:27AM EST Merit Medical Reaffirms FY22 Guidance: Net Sales $1.06B-$1.07B vs $1.07B Estimate, Adj. EPS $2.07-$2.22 vs $2.17 Est. Benzinga

09:26AM EST Merit Medical Systems Reports Deal In Principle To Settle Class Action Litigation Benzinga

09:25AM EST Merit Medical Announces Agreement in Principle to Settle Class GlobeNewswire Inc

Oct 29, 2021

07:35AM EDT Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $74 Benzinga

Oct 28, 2021

04:36PM EDT Merit Medical Systems Sees FY21 EPS $2.07-$2.22 Vs. $2.13 Est., Sales $1.06B-$1.07B Vs. $1.06B Est. Benzinga

04:35PM EDT Merit Medical Systems Q3 EPS $0.52 Beats $0.44 Estimate, Sales $267.00M Beat $260.02M Estimate Benzinga

08:26AM EDT The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug Benzinga

04:08AM EDT Earnings Scheduled For October 28, 2021 Benzinga

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 14, 2021

11:51AM EDT Merit Medical Systems Option Alert: Fri $75 Calls at the Ask: 8200 @ $0.15 vs 8215 OI; Earnings 10/28 After Close Ref=$72.29 Benzinga

Oct 5, 2021

05:48PM EDT Merit Medical Systems to Announce Third Quarter Results on October GlobeNewswire Inc

Sep 20, 2021

09:37AM EDT Merit Medical Announces Positive Results In First-in-Human Study Of WRAPSODY Cell-Impermeable Endoprosthesis RTTNews

09:27AM EDT Merit Medical Announces Results Of First-In-Human Study Of WRAPSODY Cell-Impermeable Endoprosthesis Benzinga

09:25AM EDT Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency (TLPP) rate without reintervention through 30 days, with a 12-month TLPP rate of 84.6% and a 12-month access circuit primary patency (ACPP) rate of 65.9%. GlobeNewswire Inc

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Sep 2, 2021

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

Aug 16, 2021

04:21PM EDT Merit Medical Launches One-Vac Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard Benzinga

04:05PM EDT Merit Medical Launches One-Vac Evacuated GlobeNewswire Inc

Jul 30, 2021

12:56PM EDT UPDATE: Needham On Merit Medical Price Target Raise Post-Earnings: Firm Highlights Organic Revenue Growth Improving To 29.3% From 0.6% Q/Q With New Products Gaining Traction; Sees Progress In Improving Margins & FCF On Track For $100M Annual Guidance Benzinga

08:07AM EDT Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $68 Benzinga

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

06:09AM EDT Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $83 Benzinga

Jul 29, 2021

04:53PM EDT Merit Medical Systems Raises FY21 EPS Guidance From 1.84-$1.98 To $2.07-$2.22 Vs. $1.93 Est., Raises FY21 Sales Guidance From $994M-$1.014B To $1.06B-$1.07B Vs. $1.01B Est. Benzinga

04:52PM EDT Merit Medical Systems Q2 EPS $0.62 Beats $0.44 Estimate, Sales $280.30M Beat $249.40M Estimate Benzinga

08:18AM EDT The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs Benzinga

04:23AM EDT Earnings Scheduled For July 29, 2021 Benzinga

Jul 9, 2021

04:07PM EDT Merit Medical Systems to Announce Second Quarter Results on July GlobeNewswire Inc

Apr 30, 2021

10:00AM EDT Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $73 Benzinga

08:18AM EDT Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $69 Benzinga

07:31AM EDT The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs Benzinga

Apr 29, 2021

05:24PM EDT Merit Medical Systems: Q1 Earnings Insights Benzinga

05:23PM EDT Merit Medical Systems Sees FY 2021 Net Revenue $994M-$1.014B Vs $999.65M Est Benzinga

04:52PM EDT Merit Medical Systems Q1 Adj. EPS $0.52 Beats $0.36 Estimate, Sales $248.90M Beat $230.85M Estimate Benzinga

04:51PM EDT Merit Medical Q1 EPS $0.19 Vs. Loss $0.06 Year Ago RTTNews

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

04:10AM EDT Earnings Scheduled For April 29, 2021 Benzinga

Apr 28, 2021

10:58AM EDT Merit Medical Systems Earnings Preview Benzinga

Apr 27, 2021

07:41AM EDT The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 22, 2021

08:09AM EDT The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs Benzinga

Apr 16, 2021

08:01AM EDT The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs Benzinga

Apr 15, 2021

07:49AM EDT The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split Benzinga

Apr 13, 2021

08:16AM EDT The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug Benzinga

Apr 9, 2021

09:25AM EDT Merit Medical Systems to AnnounceFirst Quarter Results GlobeNewswire Inc

Apr 8, 2021

09:25AM EDT Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference. GlobeNewswire Inc

Apr 1, 2021

07:46AM EDT The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract Benzinga

Mar 11, 2021

03:30PM EST Merit Medical Reports First Patients Enrolled In Co.'s WRAPSODY AerterioVenous Access Efficacy Pivotal Study Benzinga

03:28PM EST First Patients Enrolled in the Merit WRAPSODY AV Access Efficacy GlobeNewswire Inc

Feb 25, 2021

08:23AM EST Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $61 Benzinga

06:21AM EST Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $68 Benzinga

Feb 24, 2021

05:37PM EST Merit Medical Systems, Inc. (MMSI) Wednesday reported fourth-quarter net income of $15.4 million or $0.27 per share, compared to a loss of $4.2 million or $0.08 per share last year. RTTNews

04:54PM EST Merit Medical Systems: Q4 Earnings Insights Benzinga

04:40PM EST Merit Medical Systems Q4 Adj. EPS $0.54 Beats $0.43 Estimate, Sales $258.00M Beat $250.45M Estimate Benzinga

04:26PM EST Merit Medical Q4 EPS $0.27 Vs. Loss $0.08 Year Ago RTTNews

04:05PM EST -- Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenue -- Q4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019 -- Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019 -- Q4 2020 non-GAAP EPS* of $0.54, compared to $0.40 in Q4 2019 GlobeNewswire Inc

07:30AM EST The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO Benzinga

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 23, 2021

10:29AM EST Earnings Preview for Merit Medical Systems Benzinga

Feb 12, 2021

01:00PM EST Merit Medical Systems to Announce Fourth Quarter and Year End 2020 GlobeNewswire Inc

Feb 11, 2021

11:21AM EST Stocks That Hit 52-Week Highs On Thursday Benzinga

Feb 10, 2021

02:00PM EST Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference. GlobeNewswire Inc

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

Jan 27, 2021

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 7, 2021

04:34PM EST Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in two upcoming investor conferences. GlobeNewswire Inc

Jan 5, 2021

10:11AM EST Benzinga's Top Upgrades, Downgrades For January 5, 2021 Benzinga

05:24AM EST Needham Upgrades Merit Medical Systems to Buy, Announces $65 Price Target Benzinga

Nov 25, 2020

07:35AM EST The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback Benzinga

Nov 12, 2020

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

Nov 11, 2020

07:22AM EST Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $60 Benzinga

Nov 10, 2020

05:22PM EST Merit Medical Systems Announces Total Sales Expected To Increase At CAGR Of 5%-7% On Organic, Constant Currency, Basis, For 3 Fiscal Yrs Ending Dec. 31, 2023 Benzinga

04:05PM EST Merit Medical to Present Foundations for GlobeNewswire Inc

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Oct 30, 2020

08:09AM EDT The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts Benzinga

Oct 29, 2020

10:25AM EDT Sidoti & Co. Maintains Buy on Merit Medical Systems, Raises Price Target to $72 Benzinga

09:59AM EDT Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $51 Benzinga

09:50AM EDT Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $62 Benzinga

08:43AM EDT Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $57 Benzinga

08:23AM EDT Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $55 Benzinga

Oct 28, 2020

04:49PM EDT Merit Medical Q3 Non-GAAP EPS $0.42 Vs $0.28 Last Year RTTNews

04:34PM EDT Merit Medical Sees FY20 Net Sales $950M-$959M vs $938.8M Estimate, Adj. EPS $1.52-$1.57 vs $1.29 Est. Benzinga

04:33PM EDT Merit Medical Systems Q3 Adj. EPS $0.42 Beats $0.20 Estimate, Sales $244.00M Beat $216.31M Estimate Benzinga

04:05PM EDT -- Q3 2020 worldwide revenue of $244.0 million, up 0.4% as reported compared to Q3 2019 -- Q3 2020 core revenue on a constant currency basis* down (0.1)% compared to Q3 2019 -- Q3 2020 GAAP loss per share of $(0.05), compared to $(0.06) in Q3 2019 -- Q3 2020 non-GAAP EPS* of $0.42, compared to $0.28 in Q3 2019 GlobeNewswire Inc

Oct 13, 2020

04:09PM EDT Merit Medical Systems Finalizes Resolution With US DOJ And HHS; Co. To Pay $18M Benzinga

04:05PM EDT Merit Medical Systems Finalizes Resolution with the Government GlobeNewswire Inc

Oct 9, 2020

09:25AM EDT Merit Medical Systems to Announce Third Quarter Results on October GlobeNewswire Inc

Sep 28, 2020

06:40AM EDT Wells Fargo Upgrades Merit Medical Systems to Equal-Weight, Announces $42 Price Target Benzinga

Sep 2, 2020

05:30PM EDT Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate at four conferences in September. GlobeNewswire Inc

Jul 30, 2020

02:10PM EDT Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $55 Benzinga

12:28PM EDT Oppenheimer Maintains Outperform on Merit Medical Systems, Raises Price Target to $50 Benzinga

09:47AM EDT Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $51 Benzinga

Jul 29, 2020

04:44PM EDT Merit Medical Q2 Loss/share $0.34 Vs. Profit $0.12 Year Ago RTTNews

04:19PM EDT Merit Medical Systems Q2 EPS $0.31 Down From $0.42 YoY, Sales $218.40M Beat $192.67M Estimate Benzinga

04:06PM EDT -- Q2 2020 worldwide revenue of $218.4 million, down (14.5)% as reported compared to Q2 2019 GlobeNewswire Inc

04:04AM EDT Earnings Scheduled For July 29, 2020 Benzinga

Jul 17, 2020

09:25AM EDT Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology, oncology, critical care and endoscopy announced today that it will release its financial results for the quarter ended June 30, 2020, after the close of the stock market on Wednesday, July 29, 2020. GlobeNewswire Inc

Jul 15, 2020

11:07AM EDT Merit Medical Systems Inc. (MMSI) said that it has reached an agreement in principle with the Department of Justice to settle the DOJ's investigation of certain marketing and promotional practices. Merit currently expects to pay $18 million in connection with the resolution; however, Merit denies the allegations. RTTNews

10:07AM EDT Merit Expects To Pay $18 Mln To Settle DOJ's Investigation Of Certain Marketing And Promotional Practices RTTNews

09:33AM EDT Merit Medical Announces Agreement In Principle With Department Of Justice Benzinga

09:25AM EDT Merit Medical Announces Agreement in Principle with Department of GlobeNewswire Inc